| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.1B | $20.1B | $20.4B | $20.2B | $19.4B | $19.1B | $18.4B | $18.5B |
| Cost of Revenue | $10.5B | $12.9B | $13.4B | $14.0B | $13.5B | $12.3B | $12.4B | — |
| Gross Profit | $1.5B | $7.2B | $7.0B | $6.2B | $6.0B | $6.8B | $6.0B | $5.6B |
| R&D Expense | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.4B | $3.2B | $2.3B | $2.7B | $2.6B | $3.2B | $3.0B | $2.2B |
| Net Income | $0.5B | $2.5B | $1.8B | $1.9B | $1.8B | $2.4B | $2.2B | $1.4B |
| EPS (Basic) | $1.50 | $7.58 | $5.22 | $5.73 | $5.38 | $6.90 | $6.28 | $4.05 |
| EPS (Diluted) | $1.50 | $7.55 | $5.21 | $5.72 | $5.35 | $6.87 | $6.24 | $4.03 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.1B | $16.5B | $17.3B | $18.0B | $17.8B | $17.5B | $15.3B | $14.5B |
| Current Assets | $5.3B | $5.6B | $5.7B | $5.7B | $5.6B | $5.2B | $5.1B | $5.0B |
| Cash & Equivalents | $0.7B | $1.0B | $1.1B | $0.4B | $0.3B | $0.3B | $0.4B | $0.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $7.1B | $7.0B | $6.9B | $7.3B | $6.7B | $6.4B | $6.9B | $6.5B |
| Stockholders' Equity | $1.5B | $0.8B | $0.9B | $0.5B | $0.5B | $0.6B | $-0.0B | $-0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.8B | $3.2B | $3.5B | $2.7B | $2.7B | $3.7B | $2.7B | $3.0B |
| Investing Cash Flow | $-1.0B | $-0.1B | $-0.4B | $-0.8B | $-1.1B | $-2.3B | $-1.0B | $-0.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-2.2B | $-3.2B | $-2.4B | $-1.8B | $-1.7B | $-1.6B | $-1.8B | $-2.1B |